Kang, Hong-Yo ,Ph.D.
Institution: Chang Gung University / Kaohsiung Chang Gung Memorial Hospital
Position: Professor
Department: Graduate Institute of Clinical Medical Sciences / Hormone Research Center
Address: No.123, Ta-Pei Rd, Niao-Sung Dist., Kaohsiung City, Taiwan
Tel: +886-7-7317123ext.8898 Fax: +886-7-7336970
E-mail: hkang3@mail.cgu.edu.tw , hkang3@adm.cgmh.org.tw
Focus of Interest:
Fulltime Employment:
Education:
Honors and Awards:
Selected Main Publications:
Institution: Chang Gung University / Kaohsiung Chang Gung Memorial Hospital
Position: Professor
Department: Graduate Institute of Clinical Medical Sciences / Hormone Research Center
Address: No.123, Ta-Pei Rd, Niao-Sung Dist., Kaohsiung City, Taiwan
Tel: +886-7-7317123ext.8898 Fax: +886-7-7336970
E-mail: hkang3@mail.cgu.edu.tw , hkang3@adm.cgmh.org.tw
Focus of Interest:
- Orthopedics
- Pharmacology
- Toxicology
- Physiology
- Stem cell
Fulltime Employment:
- 2014-present Council member, Taiwan Society for Endocrinology and Metabolism
- 2012-present Steering Committee member, Food and Drug Administration, Department of Health, Executive Yuan
- 2010-present Professor, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taiwan
- 2010-present Adjunct Professor, Department of Biological Sciences, National Sun Yat-Sen University, Taiwan
- 2008-present Consultant, Center for Menopause and Reproductive Medicine, Kaohsiung Chang Gung Memorial Hospital, Taiwan
- 2003-2005 Scientific Advisor, Graduate Institute of Medical Sciences and Department of Medical Research, Changhua Christian Hospital and Chang Jung Christian University, Taiwan
Education:
- University of Rochester, Rochester, NY, USA. Post-doctoral fellow, 2000, Pathology, Urology &Biochemistry
- University of Wisconsin, Madison, WI, USA., Ph. D, 1999, Endocrinology-Reproductive Physiology
- National Taiwan University, Taipei, Taiwan, M.S., 1993, Virology
- National Taiwan University, Taipei, Taiwan, B.S., 1991, Pharmacy
Honors and Awards:
- Distinguished Grant for the Potential and Outstanding Scholars, Ministry of Science and Technology, Taiwan (2012-2015)
- Special Talent Reward, Ministry of Science and Technology, Taiwan (2010-2015)
- Young Investigator Award for 2006 International Osteoporosis Foundation of World Congress on Osteoporosis (2006)
- Young Scientist Award for 3nd Scientific Meeting of the Asia Pacific Menopause Federation (2004)
- Young Investigator Award for 1st joint meeting of the International Bone and Mineral Society and Japanese Society for Bone and Mineral Research (2003)
- Scholarship Award, Teikoku Hormone MFG.CO, Fukuoka (2002)
- Young Investigator Award for 11th International Congress on Hormone steroids (ICHS) and 7th International Congress on Hormones and Cancer (ICHC) (2002)
- Quest Diagnostics/ The 84th Endocrine Society Young Investigator Award (2002)
- The 83rd Endocrine Society Travel Grant Award for Endocrinologist (2000)
Selected Main Publications:
- Yang, Y.C., Fu, H. C., Hsiao, B. L., Sobue, G., Adachi, H., Huang, F. J., Hsuuw, Y. D., Wei, K. T., Chang, C., Huang, K. E. and Kang, H. Y.* Androgen receptor inclusions acquire GRP78/BiP to ameliorate androgen-induced protein misfolding stress in embryonic stem cells. Cell Death Dis. 4:e607.
- Kang, H. Y.* Beyond the sex hormone: Deciphering the metabolic and vascular actions of testosterone. (Editorial). J Endocrinol. 2013 Apr;217(3):C1-3. (invited editorial)
- Chou, C. K., Yang, K. D., Chou, F. F., Huang, C. C., Lan, Y. W., Lee, Y. F., Liu, R. T. and Kang, H. Y.* Prognostic Implications of miR-146b Expression and its Functional Role in Papillary Thyroid Carcinoma. J Clin Endocr Metab. 2013 Feb. 98(2):E196-E205. ( Selected by Faculty of 1000 Prime)
- Wu, C. Y., Hsieh, C. Y., Huang, K. E., Chang, C., Kang, H. Y.*. Cryptotanshinone down-regulates androgen receptor signaling by modulating lysine-specific demethylase 1 function. Int J Cancer. 2012,131(6):1423-34.
- Kang, H. Y.*, Huang, H. Y., Hsieh, C. Y., Li, C. F., Shyr, C. R., Tsai, M. Y., Chang, C. Y., Chuang, C., Huang, K. E. Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancer. J Bone Miner Res. 2009, 24(7):1180-93. (highlight by Vitamine and Hormone review)